MedWatch

New management structure in Leo Pharma

Following a number of changes to the compositon of its Board of Directors, Denmark’s Leo Pharma has now also made significant changes to its group management structure. Moreover, the group gears up for a massive acquisition, its CEO reveals.

A recent reshuffle of the boardroom in Leo Pharma and The Leo Foundation will now also have an impact on the structure of the executive management in the Danish-based drug group.

It was already well-known that a replacement would have to be found for EVP of sales and marketing Lars Olsen, as he will become Chairman of The Leo Foundation, which owns the drug group, from the turn of the year. But CEO Gitte P. Aabo has taken the opportunity to make some additional changes.

Læs hele artiklen

Få 14 dages fri adgang.

Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier